Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review Alendronate, Bisphosphonate, Diabetes, Greece, Review, Secondary osteoporosis, Treatment (anti-osteoporotic treatments)
Impact of switching oral bisphosphonates to denosumab or daily teriparatide on the progression of radiographic joint destruction in patients with biologic-naïve rheumatoid arthritis Bisphosphonate, Denosumab, Hologic, Japan, Longitudinal, Rheumatoid arthritis, Rheumatology, Secondary osteoporosis, Teriparatide, Treatment (anti-osteoporotic treatments)
Longitudinal Change in Trabecular Bone Score during and after Treatment of Osteoporosis in Postmenopausal Korean Women Alendronate, Bisphosphonate, GE-Lunar, Ibandronate, Longitudinal, Osteoporosis, South Korea, Treatment (anti-osteoporotic treatments)
Assessment of the effects of switching oral bisphosphonates to denosumab or daily teriparatide in patients with rheumatoid arthritis Bisphosphonate, Denosumab, Hologic, Japan, Longitudinal, Rheumatoid arthritis, Rheumatology, Secondary osteoporosis, Teriparatide, Treatment (anti-osteoporotic treatments)
Responses to Treatment With Teriparatide in Patients With Atypical Femur Fractures Previously Treated With Bisphosphonates Bisphosphonate, Hologic, Longitudinal, Teriparatide, Treatment (anti-osteoporotic treatments), USA
Bone Disease in Primary Hyperparathyroidism Alendronate, Bisphosphonate, Calcium, Endocrinology, Hyperparathyroidism, Review, Secondary osteoporosis, Vitamin D
TBS and BMD at the end of AI-therapy: A prospective study of the B-ABLE cohort Aromatase inhibitor, Bisphosphonate, Breast cancer, Cancer, Hologic, Longitudinal, Secondary osteoporosis, Spain, Tamoxifen, Treatment (anti-osteoporotic treatments)
Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy-Induced Osteoporosis Treated With Alendronate or Teriparatide Alendronate, Bisphosphonate, Glucocorticoids, Longitudinal, Osteoporosis, Prednisone, Secondary osteoporosis, Teriparatide, Treatment (anti-osteoporotic treatments), USA
Trabecular bone score in patients with liver transplants after 1 year of risedronate treatment. Bisphosphonate, Calcium, Hologic, Liver, Longitudinal, Risedronate, Secondary osteoporosis, Spain, Transplant, Treatment (anti-osteoporotic treatments), Vitamin D
Risedronate may preserve bone microarchitecture in breast cancer survivors on aromatase inhibitors: A randomized, controlled clinical trial Aromatase inhibitor, Bisphosphonate, Breast cancer, Cancer, Hologic, Longitudinal, Risedronate, Secondary osteoporosis, Treatment (anti-osteoporotic treatments), USA